Ann-Lii Cheng
机构：National Taiwan University Hospital
发表论文 2 篇 · 总被引 13 次 · h-index 1
代表论文
- Adjuvant pembrolizumab for participants with hepatocellular carcinoma and complete radiologic response after surgical resection or local ablation: The phase 3 keynote-937 study. (2026 · Journal of Clinical Oncology · 被引 13)
- Outcomes of sarcomatoid hepatocellular carcinoma patients treated with immunotherapy: A multi-institutional retrospective study. (2026 · Journal of Clinical Oncology)